glp 1 medication microdose FITISH GLP-1 MICRODOSING PROGRAM People Are Microdosing Weight-Loss Drugs

Understanding why it happens and how to manage it can make it easier to stay on track with your treatment

This has raised concerns about the potential risks associated with using these drugs outside their approved indications

Designed for adults with a BMI of 30 or higher, or 27 and higher with weight-related conditions, Wegovy offers significant weight reduction, with clinical trials showing a 15% average weight loss over 68 weeks

Lower Blood Sugar Levels GLP-1s (you may remember) were developed as diabetes meds

Do not inject in the same exact spot

In the second trial, SURPASS-2, tirzepatide administered at doses of 5 mg, 10 mg, or 15 mg showed superior efficacy compared to semaglutide (1 mg) in reducing body weight and HbA1c levels over 40 weeks in patients with T2DM inadequately controlled with metformin [66]